Clinical Trials in Maryland

Showing 7541-7560 of 23,284 trials

A Study of NT 201 Doses in the Treatment of Platysma Prominence

NCT05773053

The purpose of this study is to assess the safety and efficacy of NT 201 in adults with moderate to severe platysma prominence.

Platysma Prominence

Merz Aesthetics GmbH73 participantsStarted Mar 2023

Washington D.C., District of Columbia, United States • Aventura, Florida, United States • Coral Gables, Florida, United States +4 more locations

COMPLETEDPhase 319 miles

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

NCT04286438

This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with bentracimab (PB2452) in patients who present with uncontrolled major or life-threatening bleeding or who require urgent surgery or invasive procedure. At least 200 patients will be enrolled from approximately 200 centers in North America, Europe, and Asia-Pacific regions, including mainland China. Patients with reported use of ticagrelor within the prior 3 days who require urgent ticagrelor reversal will be eligible for enrollment. These populations will be enrolled based on separate inclusion criteria.

HemorrhageUrgent SurgeryInvasive Procedure

SFJ Pharmaceuticals, Inc.226 participantsStarted Jul 2020

Jacksonville, Florida, United States • Lexington, Kentucky, United States • Baltimore, Maryland, United States +65 more locations

A Study of NT 201 Doses in the Treatment of Platysma Prominence

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

Find Trials by Condition in Maryland

A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Assessment of Macrophage Activation syndromE in STill's Disease

Hypotension Prediction Index Study (HPI Study)

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Milademetan in Advanced/Metastatic Solid Tumors

PK and Dose Escalation and Expansion Study of DST-2970

Study to Compare the Use of a Behavioral Health App Versus Care As Usual for 16-22 Year Olds with Depression

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Vogelxo(R) ABPM Study in Hypogandal Men

Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)